Our results demonstrated that combined blockade of IL34 and CSF1 was protective in preclinical models of arthritis, similar to the effect seen with treatment of a TNF antagonist supporting the notion that macrophages are at the center of an inflammatory cellular circuit in mouse models of arthritis (CIA and TNFΔARE). Here, CSF1 is linked to Arthritis.